news about tirzepatide Users of Zepbound or Mounjaro Had Lower Blood Pressure in Study Weight-loss jab Mounjaro trial begins
Description
Tirzepatide is a once-weekly injectable medication that has been approved for managing type 2 diabetes

Consider booking a nutrition consult before or during tapering to lock in healthy eating patterns

Consider a protein shake when needed

The benefits of Semaglutide extend beyond weight loss
A critical hurdle in the management of GLP-1 therapies is the high rate of discontinuation

Most people lose 38 pounds in the first month once their starter dose is established, with appetite suppression often noticeable within days
